VASCULAR STENT THROMBOSIS

This adverse event was reported 2037 times

These drugs are most commonly taken by patients reporting VASCULAR STENT THROMBOSIS:

# Drug Count
0 TICAGRELOR 732
1 CLOPIDOGREL 655
2 CLOPIDOGREL BISULFATE 654
3 ASPIRIN 610
4 ASPIRIN 81 MG 603
5 ASPIRIN 325 MG 602
6 TICAGRELORE 250
7 BISOPROLOL FUMARATE 116
8 RIVAROXABAN 116
9 PRASUGREL HYDROCHLORIDE 109
See all common drugs associated with VASCULAR STENT THROMBOSIS

VASCULAR STENT THROMBOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CANGRELOR 32 0.0792
1 BIVALIRUDIN 40 0.0403
2 EPTIFIBATIDE 29 0.0376
3 TIROFIBAN 80 0.0275
4 TICAGRELOR 732 0.0228
5 PRASUGREL HYDROCHLORIDE 109 0.0107
6 FAMOTIDINE 10MG 1 0.0093
7 CLOPIDOGREL BISULFATE 654 0.0063
8 ARGATROBAN 9 0.0060
9 HEPARIN SODIUM AND DEXTROSE 4 0.0055
See all drugs enriched for association with VASCULAR STENT THROMBOSIS

VASCULAR STENT THROMBOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anti-coagulant [EPC] 47 0.0126
1 P2Y12 Platelet Inhibitor [EPC] 1236 0.0103
2 Serotonin-4 Receptor Agonist [EPC] 2 0.0030
3 Phosphodiesterase 3 Inhibitor [EPC] 14 0.0022
4 Prostacycline [EPC] 2 0.0021
5 Antifibrinolytic Agent [EPC] 20 0.0020
6 CD123 Interaction [EPC] 1 0.0019
7 alpha-Glucosidase Inhibitor [EPC] 6 0.0012
8 Platelet Aggregation Inhibitor [EPC] 632 0.0011
9 alpha-1 Adrenergic Agonist [EPC] 3 0.0007
See all drug classes enriched for association with VASCULAR STENT THROMBOSIS